Status:

COMPLETED

In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults

Lead Sponsor:

Centers for Disease Control and Prevention

Collaborating Sponsors:

Kenya Medical Research Institute

Conditions:

Malaria

HIV

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Plasmodium falciparum malaria and HIV are among the most important infectious diseases in sub-Saharan Africa. Approximately two-thirds of the estimated 35 million HIV infected persons live in sub-Saha...

Detailed Description

The study was conducted at Siaya District Hospital, in Nyanza Province, Kenya. Non-pregnant adults who provided consent to participate, who were found to have pure Plasmodium falciparum malaria parasi...

Eligibility Criteria

Inclusion

  • 18 years of age or older, not pregnant. Are able to make all follow-up visits. Are able to understand and give informed consent. Have a history of fever in past 24hrs or current axillary temperature of ³ 37.5C.
  • Have an unmixed infection with P. falciparum of at least 500 asexual parasites/mm3 as determined by microscopic examination of thick and/or thin peripheral blood smears.
  • Do not have any evidence of severe or complicated malaria (e.g., cerebral malaria, Hb \< 5 g/dL, signs and symptoms of congestive heart failure) that would require hospitalisation for treatment.
  • Have no reported allergy to sulfa drugs. Agree to HIV testing and receiving the results.

Exclusion

  • Less than 18 yrs old. Pregnant. History of allergic reactions to sulfa drugs. Have severe or complicated malaria. No history of fever. Plan to leave Siaya in next month. Do not agree to HIV testing.

Key Trial Info

Start Date :

September 1 2002

Trial Type :

INTERVENTIONAL

End Date :

July 1 2004

Estimated Enrollment :

540 Patients enrolled

Trial Details

Trial ID

NCT00144352

Start Date

September 1 2002

End Date

July 1 2004

Last Update

September 5 2005

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CDC KEMRI Research Institute

Kisumu, Kenya